<bill session="113" type="s" number="2862" updated="2015-09-01T10:22:26-04:00">
  <state datetime="2014-09-18">REFERRED</state>
  <status>
    <introduced datetime="2014-09-18"/>
  </status>
  <introduced datetime="2014-09-18"/>
  <titles>
    <title type="short" as="introduced">Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014</title>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing, and for other purposes.</title>
  </titles>
  <sponsor id="300052"/>
  <cosponsors>
    <cosponsor id="412492" joined="2014-11-13"/>
    <cosponsor id="412247" joined="2014-09-18"/>
  </cosponsors>
  <actions>
    <action datetime="2014-09-18" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
  </actions>
  <committees>
    <committee code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill relation="unknown" session="113" type="h" number="4299"/>
    <bill relation="unknown" session="113" type="h" number="4709"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Administrative remedies"/>
    <term name="Congressional oversight"/>
    <term name="Department of Justice"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Government studies and investigations"/>
    <term name="Health care coverage and access"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
</bill>
